Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection

scientific article

Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/500464
P698PubMed publication ID16479509
P5875ResearchGate publication ID7296502

P50authorLarisa GubarevaQ66732793
Frederick G HaydenQ87843428
Thomas J BracialeQ92204271
Vasiliy P MishinQ104774731
P2093author name stringMichael G Ison
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectoseltamivirQ211509
murine modelQ122890741
P1104number of pages8
P304page(s)765-772
P577publication date2006-02-13
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleComparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection
P478volume193

Reverse relations

cites work (P2860)
Q45325322A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment
Q42111794Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice
Q37379466Animal models for the study of influenza pathogenesis and therapy
Q58066873Anti-influenza therapy: the emerging challenge of resistance
Q64901554Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
Q30394067Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Q43731586Children with cancer and respiratory viral infection: epidemiology, diagnosis and treatment options
Q58614971Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus
Q30414428Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
Q38268152Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo
Q35758840Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus
Q35860081Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
Q41933615Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques
Q34597005Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.
Q37857854Influenza pharmacotherapy: present situation, strategies and hopes
Q36845779Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.
Q30364868Molecular determinants of influenza virus pathogenesis in mice.
Q30456363Newer influenza antivirals, biotherapeutics and combinations
Q34020714Oseltamivir treatment prevents the increased influenza virus disease severity and lethality occurring in chronic ethanol consuming mice
Q39092470Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
Q47593385Oseltamivir-zanamivir combination therapy suppresses drug-resistant H1N1 influenza A viruses in the hollow fiber infection model (HFIM) system
Q40094068Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection
Q37204154Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system
Q39168195Recent advances in the Overman rearrangement: synthesis of natural products and valuable compounds.
Q30392198Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice
Q30359363Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice.
Q37696588The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome
Q37618653The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures
Q30364977The role of oseltamivir in the treatment and prevention of influenza in children.
Q43873120Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

Search more.